Insider Transactions in Q4 2020 at Kiora Pharmaceuticals Inc (KPRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.35%
|
$273
$3.76 P/Share
|
|
Dec 07
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.52%
|
$273
$3.76 P/Share
|
|
Dec 07
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
588
-0.75%
|
$1,764
$3.76 P/Share
|
|
Dec 07
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.52%
|
$273
$3.76 P/Share
|
|
Nov 02
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-0.55%
|
$291
$3.51 P/Share
|
|
Nov 02
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-0.37%
|
$291
$3.51 P/Share
|
|
Nov 02
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-0.55%
|
$288
$3.51 P/Share
|
|
Nov 02
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-0.79%
|
$1,869
$3.51 P/Share
|
|
Oct 02
2020
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.56%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.38%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.55%
|
$294
$3.88 P/Share
|
|
Oct 02
2020
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
631
-0.79%
|
$1,893
$3.88 P/Share
|